JP2011503050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011503050A5 JP2011503050A5 JP2010532710A JP2010532710A JP2011503050A5 JP 2011503050 A5 JP2011503050 A5 JP 2011503050A5 JP 2010532710 A JP2010532710 A JP 2010532710A JP 2010532710 A JP2010532710 A JP 2010532710A JP 2011503050 A5 JP2011503050 A5 JP 2011503050A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- metabolism
- medicament
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000004060 metabolic process Effects 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 230000007170 pathology Effects 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL187247A IL187247A0 (en) | 2007-11-08 | 2007-11-08 | Novel synthetic analogs of sphingolipids |
| PCT/IL2008/001472 WO2009060457A1 (en) | 2007-11-08 | 2008-11-09 | Novel synthetic analogs of sphingolipids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011503050A JP2011503050A (ja) | 2011-01-27 |
| JP2011503050A5 true JP2011503050A5 (enExample) | 2011-12-22 |
Family
ID=40394267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532710A Pending JP2011503050A (ja) | 2007-11-08 | 2008-11-09 | スフィンゴリピドの新規合成アナログ |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8962891B2 (enExample) |
| EP (1) | EP2217560B1 (enExample) |
| JP (1) | JP2011503050A (enExample) |
| IL (2) | IL187247A0 (enExample) |
| WO (1) | WO2009060457A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015240465B2 (en) | 2014-04-04 | 2020-02-27 | Del Mar Pharmaceuticals | Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer |
| KR102062291B1 (ko) * | 2018-04-23 | 2020-01-03 | 주식회사 엔지켐생명과학 | 글리세롤 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 면역조절제 |
| CN113121370A (zh) * | 2021-04-25 | 2021-07-16 | 无锡市第二人民医院 | 十六烷氨丁三醇化合物、合成方法及其在抗肿瘤、抗真菌方面的应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2363082A (en) * | 1943-01-20 | 1944-11-21 | Novocol Chemical Mfg Co Inc | Anesthetic compounds, intermediates, and processes therefor |
| US2877245A (en) * | 1955-11-17 | 1959-03-10 | Lever Brothers Ltd | Process of preparing beta, beta, beta-tris (hydroxymethyl) methyl amides |
| NL125056C (enExample) | 1963-12-16 | 1900-01-01 | ||
| US3432603A (en) * | 1964-10-19 | 1969-03-11 | Sterling Drug Inc | Process for weight reduction |
| US3324043A (en) * | 1964-10-19 | 1967-06-06 | Sterling Drug Inc | Anti-oxidant compositions and process |
| JPS54147920A (en) * | 1978-05-12 | 1979-11-19 | Kureha Chem Ind Co Ltd | Pesticide for viral disease of plant |
| JPS59101448A (ja) * | 1982-11-30 | 1984-06-12 | Eisai Co Ltd | ポリプレニルカルボン酸アミドおよびその製造方法ならびにそれを含有する医薬 |
| US5068120A (en) * | 1990-08-01 | 1991-11-26 | Nabisco Brands, Inc. | Amine ester derivatives as low calorie fat mimetics |
| US5075482A (en) | 1990-08-23 | 1991-12-24 | Ciba-Geigy Corporation | Substituted 3,7,9-trioxa-1-aza-2,8-diphosphaspiro[4.5]decanes and stabilized compositions |
| US5132426A (en) | 1990-08-23 | 1992-07-21 | Ciba-Geigy Corporation | Substituted 3,7,9-trioxa-1-aza-2,8-diphosphaspiro(4,5)decanes and stabilized compositions |
| JPH069512A (ja) * | 1992-06-22 | 1994-01-18 | Kao Corp | セリノール又はその誘導体の製造方法 |
| JP2579602B2 (ja) | 1992-10-21 | 1997-02-05 | 吉富製薬株式会社 | ２−アミノ−１，３−プロパンジオール化合物および免疫抑制剤 |
| JP3768525B2 (ja) * | 1993-07-23 | 2006-04-19 | オンコメンブラン・インク | Ｎ，ｎ，ｎ−トリメチルスフィンゴシン誘導体 |
| JPH0811435A (ja) * | 1994-06-29 | 1996-01-16 | Ricoh Co Ltd | 可逆的感熱記録媒体及びその製造方法 |
| IT1271266B (it) * | 1994-12-14 | 1997-05-27 | Valle Francesco Della | Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
| JPH093467A (ja) * | 1995-06-15 | 1997-01-07 | Kao Corp | エンジン用潤滑油添加剤及びエンジン用潤滑油組成物 |
| US6410597B1 (en) | 2000-02-25 | 2002-06-25 | Virginia Commonwealth University | Hydroxyalkyl amide analogs of ceramide |
| WO2001079152A1 (en) | 2000-04-19 | 2001-10-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Sphingolipids |
| IL160850A0 (en) * | 2001-09-26 | 2004-08-31 | Yissum Res Dev Co | Sphingolipids |
| EP1436246A1 (en) * | 2001-10-16 | 2004-07-14 | SLIL Biomedical Corporation | Oligoamine compounds and derivatives thereof for cancer therapy |
| FR2834213B1 (fr) | 2001-12-27 | 2004-06-04 | Pharmascience Lab | Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations |
| AU2002951216A0 (en) * | 2002-09-05 | 2002-09-19 | Dbl Australia Pty Ltd | Surfactants and lyotropic phases formed therefrom |
| WO2004029203A2 (en) * | 2002-09-25 | 2004-04-08 | Bresagen, Inc. | Compositions and methods for enrichment of neural stem cells using ceramide analogs |
| US7323462B2 (en) * | 2002-12-10 | 2008-01-29 | Pfizer Inc. | Morpholine dopamine agonists |
| JP4216635B2 (ja) * | 2003-05-01 | 2009-01-28 | 株式会社マルハニチロ水産 | 含窒素化合物、製造法およびその利用方法 |
| JP2005272357A (ja) * | 2004-03-25 | 2005-10-06 | Astellas Pharma Inc | 抗癌剤 |
| US20050267096A1 (en) * | 2004-05-26 | 2005-12-01 | Pfizer Inc | New indazole and indolone derivatives and their use pharmaceuticals |
| WO2006116773A2 (en) * | 2005-04-28 | 2006-11-02 | The Regents Of The University Of California | Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders |
| CA2652449A1 (en) * | 2006-05-19 | 2007-11-29 | Waratah Pharmaceuticals Inc. | Screening methods for amyloid beta modulators |
-
2007
- 2007-11-08 IL IL187247A patent/IL187247A0/en unknown
-
2008
- 2008-11-09 EP EP08848560.2A patent/EP2217560B1/en not_active Not-in-force
- 2008-11-09 US US12/742,045 patent/US8962891B2/en not_active Expired - Fee Related
- 2008-11-09 WO PCT/IL2008/001472 patent/WO2009060457A1/en not_active Ceased
- 2008-11-09 JP JP2010532710A patent/JP2011503050A/ja active Pending
-
2010
- 2010-05-09 IL IL205621A patent/IL205621A0/en unknown
-
2014
- 2014-11-13 US US14/540,621 patent/US9340488B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010525055A5 (enExample) | ||
| IL255752B (en) | Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer | |
| LTPA2019504I1 (lt) | Pagerintos TM nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui | |
| JP2015525757A5 (enExample) | ||
| JP2013525444A5 (enExample) | ||
| JP2015504870A5 (enExample) | ||
| HUS1600048I1 (hu) | Készítmény Fabry-kór kezelésére | |
| JP2013014622A5 (enExample) | ||
| JP2012107057A5 (enExample) | ||
| BRPI1012116A2 (pt) | composição farmacêutica para o tratamento de doenças cardíacas | |
| JP2016515522A5 (enExample) | ||
| JP2015501783A5 (enExample) | ||
| JP2014530840A5 (enExample) | ||
| BRPI0917567A2 (pt) | tratamento de doença respiratória | |
| HUE043175T2 (hu) | Szintetikus triterpenoidok és alkalmazásuk betegség kezelésében | |
| ATE538652T1 (de) | Synergistische pharmazeutische kombination für die behandlung von krebs | |
| CL2008000461A1 (es) | Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos. | |
| JP2009536652A5 (enExample) | ||
| PT2236149E (pt) | Composição medicinal para o tratamento de doenças infeciosas respiratórias | |
| ZA201401678B (en) | Novel distributed 3,4-diamino-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases | |
| JP2013181136A5 (ja) | ポリイミド前駆体組成物、ポリイミド成形体、及び画像形成装置 | |
| JP2007520565A5 (enExample) | ||
| LT2364711T (lt) | Ekstraktų iš triušio odos, kurioje vakcinijos virusas sukėlė uždegimą, panaudojimas gamybai vaisto, skirto ūmios cerebrovaskuliarinės ligos gydymui | |
| BR112014008744A2 (pt) | preparação de libertação prolongada, e, métodos para produzir uma preparação de liberação prolongada, e para prevenir e/ou retardar o início ou suprimir a progressão da doença de alzheimer | |
| JP2013523758A5 (enExample) |